Randomized trial of combination cytokine and adult autologous bone marrow progenitor cell administration in patients with non-ischaemic dilated cardiomyopathy: The REGENERATEDCM clinical trial

European Heart Journal

Volumn 36, Issue 44, 2015, Pages 3061-3069

  Hamshere, Stephen ^a   Arnous, Samer ^a   Choudhury, Tawfiq ^a   Choudry, Fizzah ^a   Mozid, Abdul ^a   Yeo, Chia ^a   Barrett, Catherine ^a   Saunders, Natalie ^b   Gulati, Ankur ^c   Knight, Charles ^a   Locca, Didier ^a   Davies, Ceri ^a,d   Cowie, Martin R ^c   Prasad, Sanjay ^c   Parmar, Mahesh ^e   Agrawal, Samir ^b   Jones, Daniel ^a   Martin, John ^f   McKenna, William ^f   Mathur, Anthony ^a,d  

^a ST BARTHOLOMEW S HOSPITAL   (United Kingdom)

^b QUEEN MARY UNIVERSITY OF LONDON   (United Kingdom)

^c ROYAL BROMPTON HOSPITAL   (United Kingdom)

^d LONDON CHEST HOSPITAL   (United Kingdom)

^e MEDICAL RESEARCH COUNCIL   (United Kingdom)

^f UNIVERSITY COLLEGE LONDON   (United Kingdom)

Author keywords

Heart failure Dilated cardiomyopathy Stem cells Granulocyte colony stimulating factor

Indexed keywords

CD34 ANTIGEN; GRANULOCYTE COLONY STIMULATING FACTOR; PLACEBO; BRAIN NATRIURETIC PEPTIDE; PEPTIDE FRAGMENT; PRO-BRAIN NATRIURETIC PEPTIDE (1-76);

ADULT; ARTICLE; AUTOLOGOUS BONE MARROW TRANSPLANTATION; CARDIAC IMAGING; COLONY FORMING UNIT GM; CONGESTIVE CARDIOMYOPATHY; CONTROLLED STUDY; CORONARY ARTERY; CORONARY STENTING; EXERCISE; FEMALE; HEART FAILURE; HEART FUNCTION; HEART LEFT VENTRICLE EJECTION FRACTION; HUMAN; MAJOR CLINICAL STUDY; MALE; MONONUCLEAR CELL; NEW YORK HEART ASSOCIATION CLASS; NONISCHEMIC CARDIOMYOPATHY; PATIENT SAFETY; PHASE 2 CLINICAL TRIAL; PRIORITY JOURNAL; QUALITY OF LIFE; RANDOMIZED CONTROLLED TRIAL; ADULT STEM CELL; BONE MARROW TRANSPLANTATION; CARDIOMYOPATHY, DILATED; CLINICAL TRIAL; EXERCISE TOLERANCE; HEART STROKE VOLUME; METABOLISM; MIDDLE AGED; MULTIMODALITY CANCER THERAPY; PATHOPHYSIOLOGY; PHYSIOLOGY; PROCEDURES; STEM CELL TRANSPLANTATION; TRANSPLANTATION; TREATMENT OUTCOME;

ADULT STEM CELLS; BONE MARROW TRANSPLANTATION; CARDIOMYOPATHY, DILATED; COMBINED MODALITY THERAPY; EXERCISE TOLERANCE; FEMALE; GRANULOCYTE COLONY-STIMULATING FACTOR; HUMANS; MALE; MIDDLE AGED; NATRIURETIC PEPTIDE, BRAIN; PEPTIDE FRAGMENTS; QUALITY OF LIFE; STEM CELL TRANSPLANTATION; STROKE VOLUME; TREATMENT OUTCOME;

EID: 84954451405     PISSN: 0195668X     EISSN: 15229645     Source Type: Journal    
DOI: 10.1093/eurheartj/ehv390     Document Type: Article

References (21)

1. Hertz MI, Aurora P, Christie JD, Dobbels F, Edwards LB, Kirk R, Kucheryavaya AY, Rahmel AO, Rowe AW, Stehlik J, Taylor DO. Scientific Registry of the International Society for Heart and Lung Transplantation: introduction to the 2009 Annual Reports. J Heart Lung Transplant 2009;28:989-992.
2. Fuster V, Gersh BJ, Giuliani ER, Tajik AJ, Brandenburg RO, Frye RL. The natural history of idiopathic dilated cardiomyopathy. Am J Cardiol 1981;47:525-531.
3. Dec GW, Fuster V. Idiopathic dilated cardiomyopathy. N Engl J Med 1994;331: 1564-1575.
4. Jefferies JL, Towbin JA. Dilated cardiomyopathy. Lancet 2010;375:752-762.
5. Hill JM, Syed MA, Arai AE, Powell TM, Paul JD, Zalos G, Read EJ, Khuu HM, Leitman SF, Horne M, Csako G, Dunbar CE, Waclawiw MA, Cannon RP III. Outcomes and risks of granulocyte colony-stimulating factor in patients with coronary artery disease. J Am Coll Cardiol 2005;46:1643-1648.
6. Clifford DM, Fisher SA, Brunskill SJ, Doree C, Mathur A, Watt S, Martin-Rendon E. Stem cell treatment for acute myocardial infarction. Cochrane Database Syst Rev 2012;15:CD006536.
7. Gho JM, Kummeling GJ, Koudstaal S, Jansen of Lorkeers SJ, Doevendans PA, Asselbergs FW, Chamuleau SA. Cell therapy, a novel remedy for dilated cardiomy-opathy? A systematic review. J Card Fail 2013;19:494-502.
8. Fisher SA, Doree C, Mathur A, Martin-Rendon E. Meta-analysis of cell therapy trials for patients with heart failure. Circ Res 2015;116:1361-1377.
9. Vrtovec B, Poglajen G, Lezaic L, Sever M, Domanovic D, Cernelc P, Socan A, Schrepfer S, Torre-Amione G, Haddad F, Wu JC. Effects of intracoronary CD34+ stem cell transplantation in nonischemic dilated cardiomyopathy patients: 5-year follow-up. Circ Res 2013;112:165-173.
10. Arnous S, Mozid A, Mathur A. The bone marrow derived adult stem cells for dilated cardiomyopathy (REGENERATE-DCM) trial: study design. Regen Med 2011;6:525-533.
11. Kramer C, Barkhausen J, Flamm S, Kim R, Nagel E. Standardized cardiovascular magnetic resonance imaging (CMR) protocols, society for cardiovascular magnetic resonance: board of trustees task force on standardized protocols. J Cardiovasc Magn Reson 2008;10:35.
12. Abbara S, Arbab-Zadeh A, Callister T. SCCT guidelines for performance of coronary computed tomographic angiography: a report of the Society of Cardiovascular Computed Tomography Guidelines Committee. J Cardiovasc Comput Tomogr 2009; 3:190-204.
13. Abdel-Latif A, Bolli R, Tleyjeh I. Adult bone marrow-derived cells for cardiac repair: a systematic review and meta-analysis. Arch Intern Med 2007;167:989-997.
14. Abdel-Latif A, Bolli R, Zuba-Surma EK, Tleyjeh IM, Hornung CA, Dawn B. Granulo-cyte colony-stimulating factor therapy for cardiac repair after acute myocardial infarction: a systematic review and meta-analysis of randomised controlled trials. Am Heart J 2008;156:216-226.
15. Seth S, Bhargava B, Narang R, Ray R, Mohanty S, Gulati G, Kumar L, Airan B, Venugopal P, AIIMS Stem Cell Study Group. The ABCD (autologous bone marrow cells in dilated cardiomyopathy) trial a long-term follow-up study. J Am Coll Cardiol 2010;55:1643-1644.
16. Fischer-Rasokat U, Assmus B, Seeger FH, Honold J, Leistner D, Fichtlscherer S, Schächinger V, Tonn T, Martin H, Dimmeler S, Zeiher AM. A pilot trial to assess potential effects of selective intracoronary bone marrow-derived progenitor cell infusion in patients with nonischemic dilated cardiomyopathy: final 1-year results of the transplantation of progenitor cells and functional regeneration enhancement pilot trial in patients with nonischemic dilated cardiomyopathy. Circ Heart Fail 2009; 2:417-423.
17. Joseph J, Rimawi A, Mehta P, Cottler-Fox M, Sinha A, Singh BK, Pacheco R, Smith ES III, Mehta JL. Safety and effectiveness of granulocyte-colony stimulating factor in mobilizing stem cells and improving cytokine profile in advanced chronic heart failure. Am J Cardiol 2006;97:681-684.
18. Bansch D, Antz M, Boczor S, Volkmer M, Tebbenjohanns J, Seidl K, Block M, Gietzen F, Berger J, Kuck KH. Primary prevention of sudden cardiac death in idio-pathic dilated cardiomyopathy: the Cardiomyopathy Trial (CAT). Circulation 2002; 105:1453-1458.
19. Hoshikawa E, Matsumura Y, Kubo T, Okawa M, Yamasaki N, Kitaoka H, Furano T, Takata J, Doi YL. Effect of left ventricular reverse remodeling on long-term prognosis after therapy with angiotensin-converting enzyme inhibitors or angiotensin II receptor blockers and b blockers in patients with idiopathic dilated cardiomyop-athy. Am J Cardiol 2011;107:1065-1070.
20. McMurray JJ, Adamopoulos S, Anker SD, Auricchio A, Böhm M, Dickstein K, Falk V, Filippatos G, Fonseca C, Gomez-Sanchez MA, Jaarsma T, Køber L, Lip GY, Maggioni AP, Parkhomenko A, Pieske BM, Popescu BA, Rønnevik PK, Rutten FH, Schwitter J, Seferovic P, Stepinska J, Trindade PT, Voors AA, Zannad F, Zeiher A, ESC Committee for Practice Guidelines. ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure 2012: The task force for the diagnosis and treatment of acute and chronic heart failure 2012 of the European Society of Cardiology. Developed in collaboration with the Heart Failure Association (HFA) of the ESC. Eur Heart J 2012;33:1787-1847.
21. Jeevanantham V, Butler M, Saad A, Abdel-Latif A, Zuba-Surma EK, Dawn B. Adult bone marow cell therapy improves survival and induces long-term improvement in cardiac parameters: a systematic review and meta-analysis. Circ 2012;126:551-568.